In Vivo Transcriptomics-Based Framework for Systematic Indication Expansion
Zsolt Palmer, Shubham Koirala, Nabasmita Talukdar, Xiaodan Zhang, Hannah S. Garver, McKenzie Mahlmeister, Li Huang, Dimitri Joseph, Dmitry R. Leshchiner, Rama Shankar, Stephanie Wengert Watts, Xiaopeng Li, Benjamin Scott Glicksberg, Adam A Lauver, Bin Chen
This paper presents a drug repurposing framework using in vivo transcriptomics to expand indications by matching drug signatures with disease signatures, successfully recovering established uses of semaglutide and proposing new ones.
bioRxiv · Oct 14, 2026 · PreprintSystems Biology